Quoin Pharmaceuticals (QNRX) Assets (2017 - 2026)
Quoin Pharmaceuticals (QNRX) posted Assets of $15.7 million for Q1 2026, down 23.04% sequentially from $20.4 million in Q4 2025, and up 21.13% YoY from $13.0 million in Q1 2025.
Quoin Pharmaceuticals (QNRX) Assets (2017 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Assets for 10 years, with the latest figure at $15.7 million in Q1 2026.
- Quarterly Assets rose 21.13% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 21.13% YoY) and the FY2025 annual result came in at $20.4 million, up 29.8% from the prior year.
- Assets fell to $15.7 million in Q1 2026 per QNRX's latest filing, from $20.4 million in the prior quarter.
- Over five years, Assets peaked at $20.4 million in Q4 2025 and troughed at $4.3 million in Q2 2022.
- A 5-year average of $13.7 million and a median of $14.8 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2025: Assets surged 286.68% in 2023, then plunged 43.6% in 2025.
- Over 5 years, Assets stood at $14.5 million in 2022, then dropped by 15.83% to $12.2 million in 2023, then increased by 29.09% to $15.7 million in 2024, then gained by 29.8% to $20.4 million in 2025, then dropped by 23.04% to $15.7 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $15.7 million, $20.4 million, and $6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Quoin Pharmaceuticals | 491,038.58 | 491,038.58 | - | 11.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.69 Mn |
| Dec 31, 2025 | 20.39 Mn |
| Sep 30, 2025 | 6.42 Mn |
| Jun 30, 2025 | 8.91 Mn |
| Mar 31, 2025 | 12.96 Mn |
| Dec 31, 2024 | 15.71 Mn |
| Sep 30, 2024 | 11.39 Mn |
| Jun 30, 2024 | 14.05 Mn |
| Mar 31, 2024 | 16.12 Mn |
| Dec 31, 2023 | 12.17 Mn |
| Sep 30, 2023 | 15.07 Mn |
| Jun 30, 2023 | 16.71 Mn |
| Mar 31, 2023 | 18.45 Mn |
| Dec 31, 2022 | 14.46 Mn |
| Sep 30, 2022 | 16.44 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Dec 31, 2021 | 9.36 Mn |
| Dec 31, 2020 | 1.38 Mn |
| Jun 30, 2020 | 7.97 Mn |
| Jun 30, 2019 | 8.74 Mn |